Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 138 items for :

Clear All
Lars Bastholt Department of Oncology R, Odense University Hospital, Odense, Denmark

Search for other papers by Lars Bastholt in
Google Scholar
PubMed Close
,
Michael C. Kreissl Department of Nuclear Medicine, Augsburg Hospital, Augsburg
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg

Search for other papers by Michael C. Kreissl in
Google Scholar
PubMed Close
,
Dagmar Führer Department of Endocrinology and Metabolism, University Hospital Essen, Essen, Germany

Search for other papers by Dagmar Führer in
Google Scholar
PubMed Close
,
Ana L. Maia Serviço de Endocrinologia, Hospital de Clínicas de Porto Alegre, Porto Alegre

Search for other papers by Ana L. Maia in
Google Scholar
PubMed Close
,
Laura D. Locati Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan

Search for other papers by Laura D. Locati in
Google Scholar
PubMed Close
,
Léa Maciel Hospital das Clínicas de Ribeirăo Preto, Ribeirăo Preto, Brazil

Search for other papers by Léa Maciel in
Google Scholar
PubMed Close
,
Yi Wu Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Search for other papers by Yi Wu in
Google Scholar
PubMed Close
,
Kevin N. Heller AstraZeneca, Gaithersburg, Md., USA

Search for other papers by Kevin N. Heller in
Google Scholar
PubMed Close
,
Alan Webster AstraZeneca, Macclesfield, UK

Search for other papers by Alan Webster in
Google Scholar
PubMed Close
, and
Rossella Elisei Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Search for other papers by Rossella Elisei in
Google Scholar
PubMed Close

standard AE monitoring schedule. The secondary objective was to obtain information on the safety and tolerability of vandetanib, which would be compared with data from the pivotal phase III clinical trial [ 20 ]. Assessments Safety was assessed

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000448919
Volume/Issue:
Volume 5: Issue 3
Free access
Mikael Lantz Department of Endocrinology and Ophthalmology, Skåne University Hospital Malmö, Malmö
Department of Clinical Sciences, Lund University, Lund

Search for other papers by Mikael Lantz in
Google Scholar
PubMed Close
,
Jan Calissendorff Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset

Search for other papers by Jan Calissendorff in
Google Scholar
PubMed Close
,
Frank Träisk Department of Clinical Neurosciences, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden

Search for other papers by Frank Träisk in
Google Scholar
PubMed Close
,
Leif Tallstedt Department of Clinical Neurosciences, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden

Search for other papers by Leif Tallstedt in
Google Scholar
PubMed Close
,
Tereza Planck Department of Endocrinology and Ophthalmology, Skåne University Hospital Malmö, Malmö
Department of Clinical Sciences, Lund University, Lund

Search for other papers by Tereza Planck in
Google Scholar
PubMed Close
,
Ove Törring Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset

Search for other papers by Ove Törring in
Google Scholar
PubMed Close
,
Bengt Hallengren Department of Endocrinology and Ophthalmology, Skåne University Hospital Malmö, Malmö
Department of Clinical Sciences, Lund University, Lund

Search for other papers by Bengt Hallengren in
Google Scholar
PubMed Close
, and
Peter Åsman Department of Endocrinology and Ophthalmology, Skåne University Hospital Malmö, Malmö
Department of Clinical Sciences, Lund University, Lund

Search for other papers by Peter Åsman in
Google Scholar
PubMed Close

18 months. Effects of diclofenac on patient safety and laboratory parameters were registered. Patients Altogether 61 GD patients were included: 30 were randomized to adjuvant treatment with diclofenac and 31 were controls. Basal clinical

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000443373
Volume/Issue:
Volume 5: Issue 1
Free access
Jean-Charles Martin Centre de recherche en CardioVasculaire et Nutrition (C2VN), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Institut National pour la Santé Et la Recherche Médicale (INSERM), Aix Marseille Université (AMU), Marseille, France

Search for other papers by Jean-Charles Martin in
Google Scholar
PubMed Close
,
Thierry Pourcher Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat à l’Energie Atomique et aux Energies alternatives (CEA), Université Côte d’Azur (UCA), School of Medicine, Nice, France

Search for other papers by Thierry Pourcher in
Google Scholar
PubMed Close
,
Guillaume Phan Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-Santé, Fontenay-aux-Roses, France

Search for other papers by Guillaume Phan in
Google Scholar
PubMed Close
,
Julien Guglielmi Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat à l’Energie Atomique et aux Energies alternatives (CEA), Université Côte d’Azur (UCA), School of Medicine, Nice, France

Search for other papers by Julien Guglielmi in
Google Scholar
PubMed Close
,
Caroline Crambes Pharmacie Centrale des Armées (PCA), Direction des Approvisionnements en produits de Santé des Armées, Fleury-les-Aubrais, France

Search for other papers by Caroline Crambes in
Google Scholar
PubMed Close
,
François Caire-Maurisier Pharmacie Centrale des Armées (PCA), Direction des Approvisionnements en produits de Santé des Armées, Fleury-les-Aubrais, France

Search for other papers by François Caire-Maurisier in
Google Scholar
PubMed Close
,
Dalila Lebsir Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-Santé, Fontenay-aux-Roses, France

Search for other papers by Dalila Lebsir in
Google Scholar
PubMed Close
,
David Cohen Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-Santé, Fontenay-aux-Roses, France

Search for other papers by David Cohen in
Google Scholar
PubMed Close
,
Clément Rosique Centre de recherche en CardioVasculaire et Nutrition (C2VN), Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE), Institut National pour la Santé Et la Recherche Médicale (INSERM), Aix Marseille Université (AMU), Marseille, France

Search for other papers by Clément Rosique in
Google Scholar
PubMed Close
,
Lun Jing Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat à l’Energie Atomique et aux Energies alternatives (CEA), Université Côte d’Azur (UCA), School of Medicine, Nice, France

Search for other papers by Lun Jing in
Google Scholar
PubMed Close
,
Maha Hichri Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat à l’Energie Atomique et aux Energies alternatives (CEA), Université Côte d’Azur (UCA), School of Medicine, Nice, France

Search for other papers by Maha Hichri in
Google Scholar
PubMed Close
,
Lisa Salleron Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat à l’Energie Atomique et aux Energies alternatives (CEA), Université Côte d’Azur (UCA), School of Medicine, Nice, France

Search for other papers by Lisa Salleron in
Google Scholar
PubMed Close
,
Jacques Darcourt Transporter in Imaging and Radiotherapy in Oncology Laboratory (TIRO), Direction de la Recherche Fondamentale (DRF), Institut des sciences du vivant Frederic Joliot, Commissariat à l’Energie Atomique et aux Energies alternatives (CEA), Université Côte d’Azur (UCA), School of Medicine, Nice, France

Search for other papers by Jacques Darcourt in
Google Scholar
PubMed Close
,
Maamar Souidi Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-Santé, Fontenay-aux-Roses, France

Search for other papers by Maamar Souidi in
Google Scholar
PubMed Close
, and
Marc Benderitter Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-Santé, Fontenay-aux-Roses, France

Search for other papers by Marc Benderitter in
Google Scholar
PubMed Close

Introduction The Repeated Stable Iodide Prophylaxis in Accidental Situations project (PRIODAC) ( https://en.irsn.fr/research/priodac-project ) was launched by Institute for Radiation Protection and Nuclear Safety in 2014 for a duration of 8

Article Type:
Review Article
Collections:
Environment and thyroid function
DOI:
https://doi.org/10.1530/ETJ-23-0139
Volume/Issue:
Volume 13: Issue 1
Open access
Eduardo Crespo Vallejo Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain

Search for other papers by Eduardo Crespo Vallejo in
Google Scholar
PubMed Close
,
Antonio Hermosin Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain

Search for other papers by Antonio Hermosin in
Google Scholar
PubMed Close
,
Manuel Gargallo Endocrinology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain

Search for other papers by Manuel Gargallo in
Google Scholar
PubMed Close
,
Álvaro Villalba Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain

Search for other papers by Álvaro Villalba in
Google Scholar
PubMed Close
,
Eduardo Daguer Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain

Search for other papers by Eduardo Daguer in
Google Scholar
PubMed Close
,
José Flores Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain

Search for other papers by José Flores in
Google Scholar
PubMed Close
,
Javier Periañez Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain

Search for other papers by Javier Periañez in
Google Scholar
PubMed Close
,
Joaquim Amorín Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain

Search for other papers by Joaquim Amorín in
Google Scholar
PubMed Close
, and
Ernesto Santos Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Search for other papers by Ernesto Santos in
Google Scholar
PubMed Close

, 14 ). In this study, we conducted a safety (from the start of procedure up to 30 days postoperatively) and efficacy analysis (up to 24 months of follow-up) of our initial experience in ablating benign TNs (BTN) using a novel MWA system with non

Article Type:
Research Article
Collections:
Goiter and thyroid nodules
DOI:
https://doi.org/10.1530/ETJ-22-0175
Volume/Issue:
Volume 12: Issue 1
Open access
Satoshi Koyama Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Satoshi Koyama in
Google Scholar
PubMed Close
,
Naritomo Miyake Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Naritomo Miyake in
Google Scholar
PubMed Close
,
Kazunori Fujiwara Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Kazunori Fujiwara in
Google Scholar
PubMed Close
,
Tsuyoshi Morisaki Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Tsuyoshi Morisaki in
Google Scholar
PubMed Close
,
Takahiro Fukuhara Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Takahiro Fukuhara in
Google Scholar
PubMed Close
,
Hiroya Kitano Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan
Center for Head and Neck Surgery, Kusatsu General Hospital, Kusatsu, Japan

Search for other papers by Hiroya Kitano in
Google Scholar
PubMed Close
, and
Hiromi Takeuchi Department of Otolaryngology Head and Neck Surgery, Tottori University Faculty of Medicine, Yonago, Japan

Search for other papers by Hiromi Takeuchi in
Google Scholar
PubMed Close

radioiodine-refractory differentiated thyroid cancer [ 9 ]. Lenvatinib also has the possibility of improving disease control and prognosis in ATC [ 10 , 11 ]. However, the efficacy and safety of ATC have not been sufficiently considered. In Japan, lenvatinib

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000485972
Volume/Issue:
Volume 7: Issue 3
Free access
Jandee Lee Department of Surgery, Eulji University College of Medicine

Search for other papers by Jandee Lee in
Google Scholar
PubMed Close
and
Woong Youn Chung Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea

Search for other papers by Woong Youn Chung in
Google Scholar
PubMed Close

, 4 , 5 , 6 , 7 , 8 ]. The second step should be directed toward better perioperative assessment of oncologic outcomes and safety [ 1 , 5 , 6 , 7 , 8 , 9 , 10 , 11 ]. The third step would be a determination of the impact of this procedure on functional

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000350209
Volume/Issue:
Volume 2: Issue 2
Free access
Yanping Ma Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China

Search for other papers by Yanping Ma in
Google Scholar
PubMed Close
,
Tao Wu Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China

Search for other papers by Tao Wu in
Google Scholar
PubMed Close
,
Zhicheng Yao General Surgery Department, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China

Search for other papers by Zhicheng Yao in
Google Scholar
PubMed Close
,
Bowen Zheng Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China

Search for other papers by Bowen Zheng in
Google Scholar
PubMed Close
,
Lei Tan Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China

Search for other papers by Lei Tan in
Google Scholar
PubMed Close
,
Ge Tong Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China

Search for other papers by Ge Tong in
Google Scholar
PubMed Close
,
Yufan Lian Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China

Search for other papers by Yufan Lian in
Google Scholar
PubMed Close
,
Jung Hwan Baek Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Jung Hwan Baek in
Google Scholar
PubMed Close
, and
Jie Ren Department of Medical Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China

Search for other papers by Jie Ren in
Google Scholar
PubMed Close

enhances our understanding of the hydrodissection technique and might help improve the safety of time-consuming ablations. Materials and Methods Patients This study was approved by the Review Board of the Third Affiliated Hospital of Sun Yat

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000519625
Volume/Issue:
Volume 10: Issue 6
Open access
Francisco Sousa Santos Endocrinology Department, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal
Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Francisco Sousa Santos in
Google Scholar
PubMed Close
,
Rita Joana Santos Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Rita Joana Santos in
Google Scholar
PubMed Close
, and
Valeriano Leite Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Faculty of Medical Sciences of Lisbon, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed Close

as first- and second-line TKI therapies. The secondary objective was to describe safety issues associated with these therapeutic agents and their side effect profile. Radiographic and Biochemical Assessment Patients had a radiological

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000501680
Volume/Issue:
Volume 8: Issue 5
Free access
Xian Qiu Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

Search for other papers by Xian Qiu in
Google Scholar
PubMed Close
,
Lin Cheng Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

Search for other papers by Lin Cheng in
Google Scholar
PubMed Close
,
Ri Sa Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China

Search for other papers by Ri Sa in
Google Scholar
PubMed Close
,
Hao Fu Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China

Search for other papers by Hao Fu in
Google Scholar
PubMed Close
,
Yuchen Jin Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

Search for other papers by Yuchen Jin in
Google Scholar
PubMed Close
, and
Libo Chen Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

Search for other papers by Libo Chen in
Google Scholar
PubMed Close

). However, data on salvage therapy using apatinib in this entity are lacking, hampering sufficient exhibition of its efficacy and safety profile in the treatment of RR-DTC. Therefore, we conceived this open-label study based on real-world evidence to

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-21-0065
Volume/Issue:
Volume 11: Issue 2
Open access
Daniela Dias Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Daniela Dias in
Google Scholar
PubMed Close
,
Inês Damásio Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Inês Damásio in
Google Scholar
PubMed Close
,
Pedro Marques Endocrinology Department, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte (CHULN), Lisbon, Portugal

Search for other papers by Pedro Marques in
Google Scholar
PubMed Close
,
Helder Simões Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Helder Simões in
Google Scholar
PubMed Close
,
Ricardo Rodrigues Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Ricardo Rodrigues in
Google Scholar
PubMed Close
,
Branca Maria Cavaco Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed Close
, and
Valeriano Leite Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Nova Medical School: Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed Close

Capdevila J Longo F Miller W Jr Chun Bing JT Bonilla CE Chung HC Guren TK Lin CC , Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study . Cancer 2023 129 1195 – 1204 . ( https

Article Type:
Case Report
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-22-0227
Volume/Issue:
Volume 12: Issue 3
Open access